• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多个位置上的克隆特异性残基变化与抗体轻链的淀粉样蛋白形成有关。

Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.

作者信息

Morgan Gareth J, Prokaeva Tatiana

机构信息

Boston University Amyloidosis Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.

Section of Hematology and Medical Oncology, Department of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States.

出版信息

Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.

DOI:10.3389/fimmu.2025.1622207
PMID:40861476
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12375997/
Abstract

INTRODUCTION

Systemic AL amyloidosis is caused by deposition of monoclonal antibody light chains (LC) as insoluble amyloid fibrils in multiple tissues, leading to irreversible and eventually fatal organ damage. Each patient has a unique LC sequence that appears to define its propensity to aggregate. The complexity and diversity of LC sequences has impeded efforts to understand why some LCs aggregate to cause disease while others do not.

METHODS

We investigated residue changes, relative to the inferred precursor germline sequences, in monoclonal LCs associated with AL amyloidosis and multiple myeloma (MM), derived from the AL-Base resource. Consensus matrices, calculated using healthy polyclonal repertoire sequences from Observed Antibody Space (OAS), were used to determine the relative frequency of each residue in the monoclonal LC sequences.

RESULTS

A subset of residues observed in AL-associated LCs was uncommon in the healthy repertoire, but these residues were highly diverse and were also observed in MM-associated LCs. We identified multiple positions that more frequently harbor uncommon residues in AL-associated LCs than OAS-derived LCs, including several positions that have previously been identified. However, each individual residue change occurs in only a small fraction of LCs, indicating that many types of residue change can contribute to disease. Furthermore, positions where residue changes occur most frequently were not enriched in amyloidosis-associated residues.

DISCUSSION

These data provide a framework for future investigations into sequence determinants of amyloid propensity, supporting efforts towards earlier recognition and diagnosis of AL amyloidosis.

摘要

引言

系统性AL淀粉样变性是由单克隆抗体轻链(LC)以不溶性淀粉样纤维的形式沉积在多个组织中引起的,会导致不可逆转并最终致命的器官损伤。每个患者都有独特的LC序列,这似乎决定了其聚集倾向。LC序列的复杂性和多样性阻碍了人们对为何有些LC会聚集导致疾病而有些则不会的理解。

方法

我们研究了与AL淀粉样变性和多发性骨髓瘤(MM)相关的单克隆LC中相对于推断的前体胚系序列的残基变化,这些数据来自AL-Base资源。使用从观察到的抗体空间(OAS)的健康多克隆库序列计算得出的一致性矩阵,来确定单克隆LC序列中每个残基的相对频率。

结果

在与AL相关的LC中观察到的一部分残基在健康库中并不常见,但这些残基高度多样,在与MM相关的LC中也有观察到。我们确定了多个在与AL相关的LC中比源自OAS的LC更频繁地含有罕见残基的位置,包括几个先前已被确定的位置。然而,每个单独的残基变化仅发生在一小部分LC中,这表明许多类型的残基变化都可能导致疾病。此外,残基变化最频繁的位置并没有富集与淀粉样变性相关的残基。

讨论

这些数据为未来对淀粉样变性倾向的序列决定因素的研究提供了框架,支持了对AL淀粉样变性进行更早识别和诊断的努力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/ad72496af469/fimmu-16-1622207-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/2b1248678471/fimmu-16-1622207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/b089df2711ae/fimmu-16-1622207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/3c7b22d8fe19/fimmu-16-1622207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/23cc8acb55b7/fimmu-16-1622207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/fc83209724cb/fimmu-16-1622207-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/634552540a77/fimmu-16-1622207-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/d572fc0f25fe/fimmu-16-1622207-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/961139dd1337/fimmu-16-1622207-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/ad72496af469/fimmu-16-1622207-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/2b1248678471/fimmu-16-1622207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/b089df2711ae/fimmu-16-1622207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/3c7b22d8fe19/fimmu-16-1622207-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/23cc8acb55b7/fimmu-16-1622207-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/fc83209724cb/fimmu-16-1622207-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/634552540a77/fimmu-16-1622207-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/d572fc0f25fe/fimmu-16-1622207-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/961139dd1337/fimmu-16-1622207-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bbb7/12375997/ad72496af469/fimmu-16-1622207-g009.jpg

相似文献

1
Clone-specific residue changes at multiple positions are associated with amyloid formation by antibody light chains.多个位置上的克隆特异性残基变化与抗体轻链的淀粉样蛋白形成有关。
Front Immunol. 2025 Aug 1;16:1622207. doi: 10.3389/fimmu.2025.1622207. eCollection 2025.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Investigating Local Sequence-Structural Attributes of Amyloidogenic Light Chain Variable Domains.研究淀粉样轻链可变结构域的局部序列-结构属性
Proteins. 2025 Mar 4. doi: 10.1002/prot.26815.
4
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
5
The Conformational Landscape of AlphaFold2-Predicted Amyloidogenic Light Chains and Their Correlation With VL Domain Mutations and Aggregation Propensity.AlphaFold2预测的淀粉样轻链的构象景观及其与VL结构域突变和聚集倾向的相关性。
J Mol Recognit. 2025 Sep;38(5):e70011. doi: 10.1002/jmr.70011.
6
Systemic Inflammatory Response Syndrome全身炎症反应综合征
7
Recent developments in systemic light-chain amyloidosis prognosis and treatment.系统性轻链淀粉样变性病预后与治疗的最新进展
Future Cardiol. 2025 Aug;21(10):815-827. doi: 10.1080/14796678.2025.2529701. Epub 2025 Jul 12.
8
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.中枢神经系统罕见的非多发性硬化脱髓鞘疾病
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8.
9
Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis.肺炎球菌结合疫苗的免疫原性和血清效力:系统评价和网络荟萃分析。
Health Technol Assess. 2024 Jul;28(34):1-109. doi: 10.3310/YWHA3079.
10
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.

本文引用的文献

1
The Critical Role of the Variable Domain in Driving Proteotoxicity and Aggregation in Full-length Light Chains.可变结构域在全长轻链驱动蛋白毒性和聚集过程中的关键作用
J Mol Biol. 2025 Mar 1;437(5):168958. doi: 10.1016/j.jmb.2025.168958. Epub 2025 Jan 20.
2
Seeking Amyloidosis Very Early: Free light Chain Differentials and IGLV Gene Use as Screening Variables for Light-chain Amyloidosis in λ Monoclonal Gammopathies.极早期筛查淀粉样变性:游离轻链差异及IGLV基因使用作为λ单克隆丙种球蛋白病中轻链淀粉样变性的筛查变量
Br J Cancer Res. 2024 Jun;7(2):681-686. doi: 10.31488/bjcr.193. Epub 2024 May 23.
3
An updated AL-base reveals ranked enrichment of immunoglobulin light chain variable genes in AL amyloidosis.
更新后的AL数据库揭示了AL淀粉样变性中免疫球蛋白轻链可变基因的排名富集情况。
Amyloid. 2025 Jun;32(2):129-138. doi: 10.1080/13506129.2024.2434899. Epub 2024 Dec 6.
4
Predicting Structural Consequences of Antibody Light Chain N-Glycosylation in AL Amyloidosis.预测轻链型淀粉样变性中抗体轻链N-糖基化的结构后果
Pharmaceuticals (Basel). 2024 Nov 16;17(11):1542. doi: 10.3390/ph17111542.
5
Ab-Amy 2.0: Predicting light chain amyloidogenic risk of therapeutic antibodies based on antibody language model.Ab-Amy 2.0:基于抗体语言模型预测治疗性抗体的轻链淀粉样变性风险
Methods. 2025 Jan;233:11-18. doi: 10.1016/j.ymeth.2024.11.005. Epub 2024 Nov 15.
6
Amyloid nomenclature 2024: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee.淀粉样变命名 2024:更新、新蛋白及国际淀粉样变学会(ISA)命名委员会的建议。
Amyloid. 2024 Dec;31(4):249-256. doi: 10.1080/13506129.2024.2405948. Epub 2024 Sep 30.
7
Helical superstructures between amyloid and collagen in cardiac fibrils from a patient with AL amyloidosis.在一位淀粉样变性病患者的心脏原纤维中,淀粉样蛋白和胶原之间的螺旋超结构。
Nat Commun. 2024 Jul 28;15(1):6359. doi: 10.1038/s41467-024-50686-2.
8
Systemic Light Chain Amyloidosis.系统性轻链型淀粉样变性
N Engl J Med. 2024 Jun 27;390(24):2295-2307. doi: 10.1056/NEJMra2304088.
9
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.轻链突变有助于确定系统性 AL 淀粉样变性中的纤维形态。
Nat Commun. 2024 Jun 15;15(1):5121. doi: 10.1038/s41467-024-49520-6.
10
Accurate structure prediction of biomolecular interactions with AlphaFold 3.利用 AlphaFold 3 进行生物分子相互作用的精确结构预测。
Nature. 2024 Jun;630(8016):493-500. doi: 10.1038/s41586-024-07487-w. Epub 2024 May 8.